Heart patients may need only one blood thinner after balloon treatment, major trial tests

NCT ID NCT07587099

First seen Jun 27, 2026 · Last updated Jul 15, 2026 · Updated 2 times

Summary

This study looks at whether taking just one blood thinner (a P2Y12 inhibitor) is as safe and effective as taking two blood thinners (dual antiplatelet therapy) for people with stable heart disease who have a drug-coated balloon procedure without a stent. About 2,170 adults will be followed for 12 months to see rates of serious heart events and bleeding. The goal is to find a simpler treatment that reduces bleeding risk while still protecting the heart.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY HEART DISEASE (CHD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Affiliated Hospital of Jining Medical University

    RECRUITING

    Jining, Shandong, 272029, China

  • Beijing Luhe Hospital

    NOT_YET_RECRUITING

    Beijing, Beijing Municipality, China

  • Heze Municipal Hospital

    NOT_YET_RECRUITING

    Heze, Shandong, China

  • Liaocheng People's Hospital

    NOT_YET_RECRUITING

    Liaocheng, Shandong, China

  • Qingdao Municipal Hospital

    NOT_YET_RECRUITING

    Qingdao, Shandong, China

  • Shandong Provincial Hospital

    NOT_YET_RECRUITING

    Jinan, Shandong, China

  • Shandong Provincial Third Hospital

    NOT_YET_RECRUITING

    Jinan, Shandong, China

  • Shanghai Fengxian District People's Hospital

    NOT_YET_RECRUITING

    Shanghai, Shanghai Municipality, China

  • Tai'an City Central Hospital

    NOT_YET_RECRUITING

    Tai’an, Shandong, China

  • The 2nd Affiliated Hospital of Harbin Medical University

    NOT_YET_RECRUITING

    Harbin, Heilongjiang, China

  • The First Affiliated Hospital of Hainan Medical University

    NOT_YET_RECRUITING

    Haikou, Hainan, China

  • The First Affiliated Hospital of Xinjiang Medical University

    NOT_YET_RECRUITING

    Ürümqi, Xinjiang, China

  • The Second Affiliated Hospital of Nanchang University

    NOT_YET_RECRUITING

    Nanchang, Jiangxi, China

  • Zaozhuang Municipal Hospital

    NOT_YET_RECRUITING

    Zaozhuang, Shandong, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.